[go: up one dir, main page]

WO2010123472A3 - Process for making a patch containing meloxicam and lornoxicam - Google Patents

Process for making a patch containing meloxicam and lornoxicam Download PDF

Info

Publication number
WO2010123472A3
WO2010123472A3 PCT/TR2010/000071 TR2010000071W WO2010123472A3 WO 2010123472 A3 WO2010123472 A3 WO 2010123472A3 TR 2010000071 W TR2010000071 W TR 2010000071W WO 2010123472 A3 WO2010123472 A3 WO 2010123472A3
Authority
WO
WIPO (PCT)
Prior art keywords
lornoxicam
making
patch containing
containing meloxicam
meloxicam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2010/000071
Other languages
French (fr)
Other versions
WO2010123472A2 (en
Inventor
Gulgun Yener
Pinar Kilic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2010123472A2 publication Critical patent/WO2010123472A2/en
Publication of WO2010123472A3 publication Critical patent/WO2010123472A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

This invention is related to preparation of the controlled releasing parts of the transdermal therapeutic systems (patch) that contain meloxicam and lornoxicam, developed for being used in treatment of especially rheumatism (Rheumatoid Arthritis) and calcification (Osteoarthritis).
PCT/TR2010/000071 2009-04-07 2010-04-05 Process for preparing controlled releasing parts of transdermal therapeutic systems (patch) that contain meloxicam and lornoxicam Ceased WO2010123472A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2009/02671 2009-04-07
TR200902671 2009-04-07

Publications (2)

Publication Number Publication Date
WO2010123472A2 WO2010123472A2 (en) 2010-10-28
WO2010123472A3 true WO2010123472A3 (en) 2011-05-26

Family

ID=43011655

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2010/000071 Ceased WO2010123472A2 (en) 2009-04-07 2010-04-05 Process for preparing controlled releasing parts of transdermal therapeutic systems (patch) that contain meloxicam and lornoxicam

Country Status (1)

Country Link
WO (1) WO2010123472A2 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695464A (en) * 1984-10-09 1987-09-22 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
JPH01316314A (en) * 1988-06-16 1989-12-21 Taisho Pharmaceut Co Ltd poultice
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
US6203817B1 (en) * 1997-02-19 2001-03-20 Alza Corporation Reduction of skin reactions caused by transdermal drug delivery
US20050187212A1 (en) * 2002-09-17 2005-08-25 Nippon Boehringer Ingelheim Co., Ltd. Pharmaceutical composition for topical delivery of meloxicam
US20070071796A1 (en) * 2003-12-12 2007-03-29 Lts Lohmann Therapie-Systeme Ag Administration form based on cross-linked hydrophilic polymers
JP2008143866A (en) * 2006-12-12 2008-06-26 Hisamitsu Pharmaceut Co Inc Adhesive and patch

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100835074B1 (en) 2006-09-27 2008-06-03 조선대학교산학협력단 Meloxycal Transdermal Absorbent Composition and Manufacturing Method Thereof
CN1927191A (en) 2006-09-28 2007-03-14 哈尔滨健迪医药技术有限公司 Lornoxicam transdermal drug administration plaster and its preparation method

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695464A (en) * 1984-10-09 1987-09-22 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
JPH01316314A (en) * 1988-06-16 1989-12-21 Taisho Pharmaceut Co Ltd poultice
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
US6203817B1 (en) * 1997-02-19 2001-03-20 Alza Corporation Reduction of skin reactions caused by transdermal drug delivery
US20050187212A1 (en) * 2002-09-17 2005-08-25 Nippon Boehringer Ingelheim Co., Ltd. Pharmaceutical composition for topical delivery of meloxicam
US20070071796A1 (en) * 2003-12-12 2007-03-29 Lts Lohmann Therapie-Systeme Ag Administration form based on cross-linked hydrophilic polymers
JP2008143866A (en) * 2006-12-12 2008-06-26 Hisamitsu Pharmaceut Co Inc Adhesive and patch

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"Sonication", 30 October 2010 (2010-10-30), pages 1 - 2, XP002626906, Retrieved from the Internet <URL:http://en.wikipedia.org/wiki/Sonication> [retrieved on 20110301] *
Automatic translation by Thomson Scientific *
DATABASE WPI Week 199006, Derwent World Patents Index; AN 1990-040168, XP002626904 *
DATABASE WPI Week 200865, Derwent World Patents Index; AN 2008-L04796, XP002626905 *

Also Published As

Publication number Publication date
WO2010123472A2 (en) 2010-10-28

Similar Documents

Publication Publication Date Title
IL259475A (en) Combination therapy for the treatment of diabetes
PL2349106T3 (en) System for the treatment of male sexual dysfunction
WO2012118813A3 (en) Anti-il-6 receptor antibodies and methods of use
PT2544637E (en) Orthopedic device for the mechanical treatment of hallux valgus
WO2011005942A3 (en) Oligonucleotide-based compounds as inhibitors of toll-like receptors
LT2794600T (en) 2,3-dihydro-benzo[1,4]oxazine derivatives and related compounds as phosphoinositide-3 kinase (pi3k) inhibitors for the treatment of e.g. rheumatoid arthritis
EP2506712B8 (en) Morphinan derivatives for the treatment of drug overdose
HK1208231A1 (en) Treatment for rheumatoid arthritis
MY150600A (en) Use of opioid antagonists for treating urinary retention
WO2010091384A3 (en) Cadherin-11 inhibitors and methods of use thereof
WO2012040651A3 (en) Controlled release formulations of opioids
WO2011072069A3 (en) Gastric retentive pharmaceutical compositions for extended release of polypeptides
PH12017500270A1 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain
WO2010123472A3 (en) Process for making a patch containing meloxicam and lornoxicam
MX2009012096A (en) Axomadol for treating pain from arthritis.
WO2008048689A3 (en) Methods for the treatment of muscular dystrophy associated with dysferlin-deficiency
PL2326551T3 (en) Apparatus for the treatment of wastewater
HK40116506A (en) Stabilized amorphous calcium carbonate for treatment of neurological, muscular and infertility diseases or conditions
EP2575926B8 (en) Apparatus for the treatment of the blood
WO2007138577A3 (en) Methods of generating a neural tissue using muscle-derived cells
HK1235733A1 (en) Process for producing a calcium phosphate reactant, reactant obtained and use thereof in the purification of liquid effluents
UA48713U (en) Method for treating syndrome of premature ejaculation
HK1174784A (en) Sepiapterin reductase inhibitors for the treatment of pain
AU2017901156A0 (en) Process for the Treatment of Sludge
AU2008903353A0 (en) Process for the treatment of water and associated applications of treated water

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10739407

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10739407

Country of ref document: EP

Kind code of ref document: A2